GENE ONLINE|News &
Opinion
Blog

LATEST
Asia-Pacific CDMO
Fujifilm Expands CDMO Operations by Buying Atara’s Cell Therapy Plant for $100 Million
2022-01-27
Trials & Approvals
Cartesian’s Off-the-shelf RNA Therapy for Myeloma Enters Clinical Trials
2022-01-27
Startups Microbiome
RumenEra Sets Out to Curb Gas by Researching Cows
2022-01-26
Funding COVID-19
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Deals Microbiome
OpenBiome and the University of Minnesota collaborate to give Microbes to those in Need
2022-01-26
R&D Bispecific Antibody
The Lancet Publishes Data on Roche’s Long-Lasting Bispecific Antibody for Vision Loss
2022-01-25
Manufacturing SPAC
Psychedelics Player Goes Public via SPAC
2022-01-25
Innovation Nanoparticle
Left, or Right? Orientation of Nanoparticles Influences Immune Response and Maturation
2022-01-25
Trials & Approvals COVID-19
Remdesivir Cleared for Treating Non-Hospitalized COVID-19 Patients
2022-01-24
Special China
Biotech Showcase 2022: The China Factor
2022-01-24
Trials & Approvals Bristol Myers Squibb
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
Asia-Pacific CDMO
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
M&A Epilepsy
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
Asia-Pacific CRO
APAC CRO Novotech Mulls IPO after $255 Million Round
2022-01-20
Go Prime NASDAQ
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
1 … 100 101 102 103 104 … 218
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top